Lamotrigin Viatris 100 mg tablets

Lamotrigin Viatris is a generic pharmaceutical product used primarily to treat epilepsy and bipolar disorder. The brand Viatris was formed in 2020 through a high-profile merger between Mylan and Upjohn, a former division of Pfizer. This strategic combination created a global healthcare giant focused on providing access to high-quality medicines across various therapeutic areas.

Because Viatris is a massive global manufacturer, Lamotrigin is produced in multiple facilities worldwide, often depending on the specific regional market and supply chain requirements. The company is headquartered in the United States and maintains a significant global footprint, marketing products in over 165 countries. As a generic drug, it provides a cost-effective alternative to the original brand-name version, GSK's Lamictal, while maintaining the same clinical efficacy and safety standards.